Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1L. Képénékian, P. Combemale, Thomas Mognetti et al.|European Journal of Endocrinology|2016Cited by 69
French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1Pierre Goudet, Antoine Tabarin, Thomas Cuny et al.|Annales d Endocrinologie|2023Cited by 28
Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CTAurélie Moreau, C. Houzard, Anne‐Laure Giraudet et al.|Nuclear Medicine Communications|2017Cited by 11
Biomarkers Improving Genetic and Metastatic Disease Prediction in Paraganglioma: Insights From a Prospective StudyTom Drossart, Justine Cristante, Alexandre Buffet et al.|The Journal of Clinical Endocrinology & Metabolism|2024Cited by 8
FDOPA Patterns in Adrenal GlandsAurélie Moreau, C. Houzard, Anne‐Laure Giraudet et al.|Clinical Nuclear Medicine|2017Cited by 4